{"id":"https://openalex.org/W2004728641","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p2-12-25","title":"P2-12-25: Blinded Multi-Site Validation of a Pathology-Based Prognostic Marker Profile for Operable Hormone Receptor-Positive Breast Cancer.","display_name":"P2-12-25: Blinded Multi-Site Validation of a Pathology-Based Prognostic Marker Profile for Operable Hormone Receptor-Positive Breast Cancer.","publication_year":2011,"publication_date":"2011-12-01","ids":{"openalex":"https://openalex.org/W2004728641","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p2-12-25","mag":"2004728641"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs11-p2-12-25","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p2-12-25","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs11-p2-12-25","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009371859","display_name":"Steven P. Linke","orcid":"https://orcid.org/0000-0001-8584-4947","observed_orcids":["https://orcid.org/0000-0001-8584-4947"]},"institutions":[{"id":"https://openalex.org/I4210108016","display_name":"Prediction Sciences (United States)","ror":"https://ror.org/0114c6692","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SP Linke","raw_affiliation_strings":["1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","Prediction Sciences, La Jolla, CA","Seattle Breast Pathology Consultants, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Prediction Sciences, La Jolla, CA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034230229","display_name":"Troy M. Bremer","orcid":"https://orcid.org/0000-0001-6100-605X","observed_orcids":["https://orcid.org/0000-0001-6100-605X"]},"institutions":[{"id":"https://openalex.org/I4210108016","display_name":"Prediction Sciences (United States)","ror":"https://ror.org/0114c6692","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"TM Bremer","raw_affiliation_strings":["1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","Prediction Sciences, La Jolla, CA","Seattle Breast Pathology Consultants, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Prediction Sciences, La Jolla, CA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079133518","display_name":"AK Man","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108016","display_name":"Prediction Sciences (United States)","ror":"https://ror.org/0114c6692","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"AK Man","raw_affiliation_strings":["1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","Prediction Sciences, La Jolla, CA","Seattle Breast Pathology Consultants, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Prediction Sciences, La Jolla, CA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038303596","display_name":"KJ Bloom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108016","display_name":"Prediction Sciences (United States)","ror":"https://ror.org/0114c6692","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"KJ Bloom","raw_affiliation_strings":["1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","Prediction Sciences, La Jolla, CA","Seattle Breast Pathology Consultants, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Prediction Sciences, La Jolla, CA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018792947","display_name":"T. L. Lawton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108016","display_name":"Prediction Sciences (United States)","ror":"https://ror.org/0114c6692","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"TJ Lawton","raw_affiliation_strings":["1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","Prediction Sciences, La Jolla, CA","Seattle Breast Pathology Consultants, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prediction Sciences, La Jolla, CA; Clarient, Inc., Aliso Viejo, CA; Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Prediction Sciences, La Jolla, CA","institution_ids":["https://openalex.org/I4210108016"]},{"raw_affiliation_string":"Seattle Breast Pathology Consultants, Seattle, WA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210108016"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.1058446,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"24_Supplement","first_page":"P2","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/operable-breast-cancer","display_name":"operable breast cancer","score":0.7279999852180481},{"id":"https://openalex.org/keywords/estrogen-receptor","display_name":"estrogen receptor","score":0.5559999942779541},{"id":"https://openalex.org/keywords/progesterone-receptor","display_name":"progesterone receptor","score":1.0},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.9929999709129333},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.9900000095367432},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.9950000047683716},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9980000257492065},{"id":"https://openalex.org/keywords/distant-metastasis","display_name":"distant metastasis","score":0.9279999732971191},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.6150000095367432},{"id":"https://openalex.org/keywords/hormone-therapy","display_name":"hormone therapy","score":0.4970000088214874},{"id":"https://openalex.org/keywords/multi-site-validation","display_name":"multi-site validation","score":0.6209999918937683},{"id":"https://openalex.org/keywords/tissue-microarray","display_name":"tissue microarray","score":0.718999981880188},{"id":"https://openalex.org/keywords/clinicopathological-features","display_name":"clinicopathological features","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7505470514297485},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7447633147239685},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6441826820373535},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6321756839752197},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5400176644325256},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.5388476848602295},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.4992396831512451},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.4925547242164612},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.49088054895401},{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.436354398727417},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.33560577034950256},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1040082573890686},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs11-p2-12-25","doi":"https://doi.org/10.1158/0008-5472.sabcs11-p2-12-25","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs11-p2-12-25","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2049550987","https://openalex.org/W1991053809","https://openalex.org/W2321004702","https://openalex.org/W2324154615","https://openalex.org/W4408099001","https://openalex.org/W2086982873","https://openalex.org/W7162552744","https://openalex.org/W2016199568","https://openalex.org/W3111663601","https://openalex.org/W2152121590"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"We":[2],"previously":[3],"reported":[4],"development":[5],"and":[6,39,44,62,96,122,153,157,192,202,234,247,276,286,297,355,371,382,405,423,428],"preliminary":[7],"validation":[8,82],"of":[9,16,83,188,204,230,238,262,270,278,295,305,329,341,363,431,441],"a":[10,14,87,103,208,215,221,228,235,302,337,420],"marker":[11],"profile":[12,32,85,373,404,434],"with":[13,21,124,132,148,327,399],"risk":[15,56,205,222,249,357,375,384],"recurrence":[17],"algorithm":[18,210,219,267,422],"for":[19,138,145,254,413],"patients":[20,116,244,272,280,351,365,377],"operable":[22],"hormone":[23,133],"receptor":[24],"(HR)-positive":[25],"breast":[26,128,330,445],"cancer":[27,129,331,446],"using":[28,106,207,323,419],"tissue":[29,151],"microarrays.":[30],"The":[31,98,218,266,284],"includes":[33],"ER,":[34],"PR,":[35],"HER2,":[36],"EGFR,":[37],"BCL2,":[38],"p53":[40],"(assessed":[41,46],"by":[42,47,75,162],"IHC)":[43],"MYC/8q24":[45],"FISH).":[48],"It":[49],"also":[50,348],"directly":[51],"incorporates":[52],"the":[53,66,76,84,167,263,271,279,334,343,350,364,368,372,379,388,403,426,432,438],"standard":[54,338],"clinicopathologic":[55,400],"factors":[57],"tumor":[58,60,141,150,406],"size,":[59],"grade,":[61],"nodal":[63],"status":[64],"to":[65,224,232,242,387,435],"extent":[67],"that":[68],"their":[69],"prognostic":[70,427],"value":[71],"is":[72],"not":[73],"replaced":[74],"molecular":[77],"markers.":[78],"Here,":[79],"we":[80],"demonstrate":[81],"in":[86,102,260,301,367,378,444],"blinded":[88,104,417],"multi-site":[89],"study":[90,99],"conducted":[91,101,212],"on":[92,227],"whole":[93],"sections.":[94],"Material":[95],"methods:":[97],"was":[100,240,258],"fashion":[105],"an":[107,315],"independent":[108],"data":[109,159,253],"management":[110],"firm":[111],"(Synteract,":[112],"Carlsbad,":[113],"CA).":[114],"Eligible":[115],"were":[117,143,160,211,320,366,408],"females":[118],"diagnosed":[119],"between":[120],"1985":[121],"1997":[123],"HR-positive":[125],"stage":[126],"I-IIIA":[127],"treated":[130],"only":[131,361,402],"therapy":[134],"after":[135],"definitive":[136],"surgery":[137],"whom":[139],"sufficient":[140],"samples":[142],"available":[144],"testing.":[146],"Slides":[147],"FFPE":[149],"sections":[152],"associated":[154],"clinicopathologic,":[155],"treatment,":[156],"outcome":[158],"provided":[161],"four":[163],"clinical":[164,429],"sites":[165],"through":[166,311],"NCI-funded":[168],"Cooperative":[169],"Breast":[170],"Cancer":[171,176,450],"Tissue":[172],"Resource":[173],"program:":[174],"Fox-Chase":[175],"Center":[177],"(Philadelphia,":[178],"PA)":[179],"(n=106),":[180],"Kaiser":[181],"Permanente":[182],"Northwest":[183],"(Portland,":[184],"OR)":[185],"(n=165),":[186],"University":[187,194],"Miami":[189],"(FL)":[190],"(n=55),":[191],"Washington":[193],"St.":[195],"Louis":[196],"(MO)":[197],"(n=74).":[198],"Marker":[199],"assays,":[200],"scoring,":[201],"calculation":[203],"scores":[206],"predefined":[209,236,421],"at":[213],"Clarient,":[214],"CLIA-certified":[216],"laboratory.":[217],"assigned":[220],"score":[223,340],"each":[225],"patient":[226,288,390],"scale":[229],"0":[231],"10+,":[233],"threshold":[237,339],"3.8":[239],"used":[241],"separate":[243],"into":[245,353],"low":[246,354],"high":[248,356,383],"groups.":[250],"Results:":[251],"Complete":[252],"all":[255],"seven":[256],"markers":[257],"obtained":[259],"349":[261],"400":[264],"patients.":[265,447],"defined":[268],"28%":[269],"(n=99)":[273],"as":[274,282,333],"high-risk":[275,285],"72%":[277],"(n=250)":[281],"low-risk.":[283],"low-risk":[287,369],"groups":[289,358],"had":[290],"10-year":[291],"distant":[292],"metastasis":[293],"rates":[294],"34%":[296],"9%,":[298],"respectively,":[299],"resulting":[300],"hazard":[303],"ratio":[304],"4.7":[306],"(95%":[307],"CI,":[308],"2.3\u22127.8,":[309],"p<0.0001)":[310],"10":[312],"years":[313],"without":[314],"intermediate-risk":[316],"group.":[317],"Similar":[318],"results":[319],"achieved":[321],"when":[322],"disease-specific":[324],"survival":[325],"(death":[326],"evidence":[328],"recurrence)":[332],"outcome.":[335],"Using":[336],"3.4,":[342],"Nottingham":[344],"Prognostic":[345],"Index":[346],"(NPI)":[347],"stratified":[349,376],"(n=349)":[352],"(p=0.03),":[359],"but":[360],"10%":[362],"category,":[370],"further":[374],"NPI":[380],"intermediate":[381],"categories":[385],"similar":[386],"overall":[389],"set":[391],"(p<0.001).":[392],"In":[393],"multivariate":[394],"Cox":[395],"proportional":[396],"hazards":[397],"analysis":[398],"factors,":[401],"size":[407],"significant":[409],"(Wald":[410],"statistic":[411],"p<0.001":[412],"both).":[414],"Discussion:":[415],"This":[416],"study,":[418],"threshold,":[424],"validates":[425],"utility":[430],"multi-marker":[433],"help":[436],"guide":[437],"appropriate":[439],"level":[440],"adjuvant":[442],"treatment":[443],"Citation":[448],"Information:":[449],"Res":[451],"2011;71(24":[452],"Suppl):Abstract":[453],"nr":[454],"P2-12-25.":[455]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}